Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters-Reference-Cited by-同舟云学术

Tamoxifen Use in Postmenopausal Breast Cancer: CYP2D6 Matters

Published:2013-01-10 Issue:2 Volume:31 Page:176-180
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Brauch Hiltrud¹,Schroth Werner¹,Goetz Matthew P.²,Mürdter Thomas E.¹,Winter Stefan¹,Ingle James N.²,Schwab Matthias³,Eichelbaum Michel¹

Affiliation:

1. Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; and University Tübingen, Tübingen, Germany

2. Mayo Clinic, Rochester, MN

3. Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart; University Tübingen; and Institute of Experimental and Clinical Pharmacology and Toxicology, University Hospital Tübingen, Tübingen, Germany

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2012.44.6625

Reference34 articles.

1. CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women with Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

2. CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients

3. CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned

4. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

5. Re: CYP2D6 Genotype and Tamoxifen Response in Postmenopausal Women With Endocrine-Responsive Breast Cancer: The Breast International Group 1-98 Trial

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and in‐silico study of novel triarylethylene analogs with dual anti‐estrogenic and serotonergic activity;Drug Development Research;2023-10-25

2. Chromosome 22;Cancer Genes: Volume 2;2023-08-16

3. Flexible Etherified and Esterified Triphenylethylene Derivatives and Their Evaluation on ER‐positive and Triple‐Negative Breast Cancer Cell Lines;ChemMedChem;2022-02-17

4. Manipulating Estrogenic/Anti-Estrogenic Activity of Triphenylethylenes towards Development of Novel Anti-Neoplastic SERMs;International Journal of Molecular Sciences;2021-11-22

5. Selective estrogen receptor modulator, tamoxifen, inhibits Zika virus infection;Journal of Medical Virology;2021-08-04